Showing results (231-240 of 466) with videos related to
Sort By:
Pageof 47
Bone Marrow Transplantation|December 3, 2003
Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimensS Chakrabarti, D W Milligan, J Brown, et al.International Journal of Dermatology|November 1, 1991
Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma. Complexity of objective evaluationM A Oziemski, S P Rockman, D I Marks, et al.Cancer|March 7, 2018
Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemiaHagop M Kantarjian, Yun Su, Elias J Jabbour, et al.Investigative Radiology|January 1, 1991
Pre- to postnatal reduction in ultrasound attenuation coefficient of the liverP L Carson, E H Chiang, J M Rubin, et al.Cancer Genetics and Cytogenetics|May 1, 1995
Translocation 11;14 in newly diagnosed chronic myelogenous leukemiaA Magdalinski, H Drwinga, P Crilley, et al.Expert Review of Hematology|January 8, 2025
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature reviewDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2013
Recovery of a top predator mediates negative eutrophic effects on seagrassBrent B Hughes, Ron Eby, Eric Van Dyke, et al.American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.Bone Marrow Transplantation|May 13, 1998
Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantationV L Grandage, J M Cornish, D H Pamphilon, et al.Bone Marrow Transplantation|March 1, 1995
Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantationP Crilley, D Topolsky, M J Styler, et al.Pageof 47